DNA Damage Repair Defects and Targeted Radionuclide Therapies for Prostate Cancer: Does Mutation Really Matter? A Systematic Review

The aim of the present review was to assess the impact of DNA damage repair (DDR) mutations on response and outcome of patients (pts) affected by advanced prostate cancer (PCa) submitted to radionuclide therapies with [(223)Ra]RaCl(2) ((223)Ra-therapy) or prostate specific membrane antigen (PSMA) li...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippi, Luca, Palumbo, Barbara, Bagni, Oreste, Frantellizzi, Viviana, De Vincentis, Giuseppe, Schillaci, Orazio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860912/
https://www.ncbi.nlm.nih.gov/pubmed/36676004
http://dx.doi.org/10.3390/life13010055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860912/
https://www.ncbi.nlm.nih.gov/pubmed/36676004
http://dx.doi.org/10.3390/life13010055

Ejemplares similares